Inorganic Chemistry
ARTICLE
2142vs, 2097vs, 1494w, 1438s, 1385m, 1163w, 1061m, 1022m, 801w,
729w, 639m, 610m cmꢀ1. Anal. Calcd for C20H30N3Sm: C, 51.90; H,
6.53; N, 9.08. Found: C, 51.81; H, 6.43; N, 9.08. MS (ESI, MeCN) m/z
(rel intensity): 506.2 (100) {[(C5Me5)2Sm(N3)](N3)}ꢀ, 967.3 (28)
{[(C5Me5)2Sm(N3)]2(N3)}ꢀ, 1429.6 (8) {[(C5Me5)2Sm(N3)]3-
(N3)}ꢀ, 1894.9 (8) {[(C5Me5)2Sm(N3)]4(N3)}ꢀ.
[(C5Me5)2Sm(NCMe)(μ-N3)]3, 6. Yellow X-ray quality crystals of
6 were grown from a saturated solution of 5 in acetonitrile at ꢀ30 ꢀC.
When the mother liquor was removed and the crystals were allowed to
dry by evaporation, they became dull and dark yellow in color. These
dried solids were indistinguishable from 5 when analyzed by 1H NMR
and IR spectroscopy.
{[(C5Me5)2Sm(μ-N3)][(C5Me5)2Sm(NCMe)(μ-N3)]}n, 7. Yel-
low X-ray quality crystals of 7 were grown over 3 d by allowing a
concentrated solution of 5 in hot acetonitrile to cool slowly to room
temperature. The IR spectrum of these crystals was identical to that of
crude 5 isolated as a powder, except that an additional shoulder was
observed at 2090 cmꢀ1 in the azide stretching region.
[(C5Me5)2Y(OCMe2)2][BPh4], 8. A 100 mL Schlenk flask was
charged with a solution of 1 (70 mg, 0.10 mmol) in benzene (20 mL) in
the glovebox and transferred to a Schlenk line. The flask was connected
via a T-joint to another 100 mL Schlenk flask containing a 10:1 benzene/
acetone mixture (20 mL). Under a static atmosphere of dinitrogen, both
flasks were opened to allow slow diffusion of acetone into the solution of
1. Over 2 d, light yellow needle-like crystals formed in the colorless
solution. The crystals were collected by filtration, washed with benzene
and hexane, and dried under vacuum to obtain 8 (74 mg, 91%). 1H NMR
(THF-d8): δ 7.32 (br s, o-BPh4, 8H), 6.88 (t, 3JHH = 7.0 Hz, m-BPh4,
8H), 6.74 (t, 3JHH = 7.0 Hz, p-BPh4, 4H), 2.24 (s, Me2CO, 12H), 1.85 (s,
C5Me5, 30H). 13C NMR (THF-d8): δ 204.3 (Me2CO), 165.4 (BPh4),
137.4 (BPh4), 126.0 (BPh4), 122.1 (BPh4), 119.9 (C5Me5), 32.5
(Me2CO), 11.2 (C5Me5). IR: 3055s, 2984s, 2906s, 2863s, 1942w,
1881w, 1814w, 1772w, 1678vs, 1581s, 1480s, 1427s, 1370s, 1247s,
1183m, 1148m, 1067m, 1031m, 914w, 848m, 734vs, 706vs,
613s cmꢀ1. Anal. Calcd for C50H62BO2Y: C, 75.56; H, 7.86. Found:
C, 75.16; H, 7.42. MS (ESI, THF) m/z (rel intensity): 359.1 (26)
[(C5Me5)2Y]þ, 417.2 (100) [(C5Me5)2Y(OCMe2)]þ, 431.2 (97)
[(C5Me5)2Y(THF)]þ, 489.2 (3) [(C5Me5)2Y(OCMe2)(THF)]þ.
[(C5Me5)2Y(OCMe2)2][BPh4], 8, from [(C5Me5)2Y(THF)2]-
[BPh4] and Acetone. Two equivalents of acetone were vacuum
transferred to a frozen (ꢀ196 ꢀC) colorless solution of [(C5Me5)2Y-
(THF)2][BPh4] prepared from 1 (10 mg, 0.015 mmol) in THF-d8
(0.5 mL) in a J-Young NMR tube. The reaction mixture was warmed to
room temperature and over 15 min turned pale yellow. Complex 8 was
observed by 1H NMR spectroscopy as the only product.
solution immediately became red, and after 15 min of stirring the red
slurry was centrifuged and the supernatant discarded. The insoluble
material was washed with benzene and hexane and dried under vacuum
to yield 10 as a red orange powder (84 mg, 86%). When the reaction
mixture was filtered immediately after combining reagents and layered
with hexane, slow evaporation over 5 d yielded X-ray quality crystals. 1H
NMR (THF-d8, 5 ꢀC): δ 7.78 (d, 3JHH = 7.5 Hz, o-Ph2CO, 8H), 6.64 (br
s, m-Ph2CO, 4H), 7.60 (t, 3JHH = 7.5 Hz, m-Ph2CO, 4H), 7.50 (t, 3JHH
=
7.5 Hz, p-Ph2CO, 4H), 7.30 (m, o-BPh4, 8H), 6.86 (t, 3JHH = 7.0 Hz, m-
BPh4, 8H), 6.72 (t, 3JHH = 7.0 Hz, p-BPh4, 4H), 1.92 (s, C5Me5, 30H).
13C NMR (THF-d8, 5 ꢀC): δ 196.1 (Ph2CO), 165.3 (BPh4), 137.3
(BPh4), 133.2 (Ph2CO), 130.9 (Ph2CO), 129.2 (Ph2CO), 125.9 (BPh4),
122.0 (BPh4), 121.1 (C5Me5), 11.9 (C5Me5). 11B NMR (THF-d8,
ꢀ70 ꢀC): δ ꢀ5.99 (BPh4). IR: 3055m, 3033m, 3000m, 2982m,
2941m, 2905m, 2859m, 2156w, 1939w, 1879w, 1819w, 1656w, 1603s,
1558s, 1480s, 1448s, 1381m, 1327s, 1294s, 1160s, 1078m, 1032m,
999s, 941s, 842s, 810m, 771s, 734s, 705s, 636s, 613s cmꢀ1. Anal. Calcd
for C70H70BO2Y: C, 80.61; H, 6.76. Found: C, 80.64; H, 6.91.
[(C5Me5)2Y(OCPh2)2][BPh4], 10, from [(C5Me5)2Y(THF)2]-
[BPh4] and Benzophenone. A solution of [(C5Me5)2Y(THF)2]-
[BPh4] prepared from 1 (18 mg, 0.027 mmol) in THF (3 mL) was
combined with a solution of benzophenone (12 mg, 0.067 mmol) in
THF (1 mL). A red solution immediately formed, and the solvent was
removed under vacuum. Analysis of the resulting tacky red residue by 1H
NMR spectroscopy showed residual Ph2CO and 10 as the only
organometallic product.
[(C5Me5)2Sm(OCPh2)2][BPh4], 11. A solution of 2 (22 mg, 0.030
mmol) in benzene (5 mL) was added to a stirred solution of benzo-
phenone (12 mg, 0.067 mmol) in benzene (5 mL). The maroon red
solution quickly turned dark red and then to red orange. After 15 min of
stirring, the red slurry was centrifuged and the supernatant discarded.
The insoluble material was washed with benzene and hexane and dried
1
under vacuum to yield 11 as a red orange powder (25 mg, 75%). H
NMR (THF-d8, 5 ꢀC): δ 7.54 (t, 3JHH = 7.5 Hz, p-Ph2CO, 4H), 7.38 (br
s, o/m-Ph2CO, 16H), 7.20 (m, o-BPh4, 8H), 6.83 (t, 3JHH = 7.0 Hz, m-
BPh4, 8H), 6.73 (t, 3JHH = 7.0 Hz, p-BPh4, 4H), 0.92 (s, C5Me5, 30H).
13C NMR (THF-d8, 5 ꢀC): δ 165.2 (BPh4), 137.2 (BPh4), 134.0
(Ph2CO), 130.8 (Ph2CO), 129.2 (Ph2CO), 125.9 (BPh4), 122.0
(BPh4), 119.0 (C5Me5), 18.7 (C5Me5). The 13C resonance for Ph2CO
was not located. 11B NMR (THF-d8, ꢀ70 ꢀC): δ ꢀ6.06 (BPh4). IR:
3055m, 3034m, 2982m, 2905m, 2859m, 2728w, 2332w, 2239w, 1940w,
1818w, 1759w, 1656w, 1603s, 1554s, 1480s, 1448s, 1426s, 1383m,
1326s, 1291s, 1180s, 1159s, 1077s, 1032s, 999s, 976m, 941s, 923s, 842s,
811m, 770s, 734s, 704s, 636s, 613 cmꢀ1. Anal. Calcd for C70H70BO2Sm:
C, 76.12; H, 6.39. Found: C, 76.00; H, 6.31.
[(C5Me5)2Sm(OCMe2)2][BPh4], 9. As described for 8, acetone
was allowed to diffuse slowly into a solution of 2 (55 mg, 0.070 mmol) in
benzene (6 mL) yielding red orange needle-like crystals. The crystals
were washed with benzene and hexane and dried under vacuum to
obtain 9 (55 mg, 91%). 1H NMR (THF-d8): δ 7.17 (br s, o-BPh4, 8H),
6.79 (t, 3JHH = 7.0 Hz, m-BPh4, 8H), 6.68 (t, 3JHH = 7.0 Hz, p-BPh4, 4H),
1.18 (s, Me2CO, 12H), 0.77 (s, C5Me5, 30H). 13C NMR (THF-d8): δ
217.1 (Me2CO), 165.2 (BPh4), 137.2 (BPh4), 125.8 (BPh4), 122.0
(BPh4), 118.1 (C5Me5), 30.2 (Me2CO), 18.5 (C5Me5). IR: 3054s, 2984s,
2906s, 2861s, 1942w, 1880w, 1814w, 1772w, 1676vs, 1581s, 1480s,
1427s, 1370s, 1246s, 1183m, 1148m, 1067m, 1031m, 914w, 847m,
734vs, 706vs, 606s cmꢀ1. Anal. Calcd for C50H62BO2Sm: C, 70.14; H,
7.30. Found: C, 69.45; H, 7.28. MS (ESI, THF) m/z (rel intensity):
422.1 (22) [(C5Me5)2Sm]þ, 480.2 (33) [(C5Me5)2Sm(OCMe2)]þ,
494.2 (100) [(C5Me5)2Sm(THF)]þ, 552.2 (5) [(C5Me5)2Sm(OCMe2)-
(THF)]þ.
[(C5Me5)2Y(phen)][BPh4], 12. A solution of phenanthroline (10
mg, 0.055 mmol) in benzene (3 mL) was added to a stirred solution of 1
(36 mg, 0.053 mmol) in benzene (10 mL). The mixture immediately
turned cloudy yellow. After 15 min, the insoluble material was obtained
by centrifugation and removal of the supernatant. The solids were dried
under vacuum to yield 12 as a bright yellow powder (43 mg, 94%).
Crystals suitable for X-ray diffraction were grown over several days from
a concentrated THF solution at ꢀ35 ꢀC. 1H NMR (THF-d8, 5 ꢀC): δ
8.47 (m, phen, 4H), 7.92 (s, phen, 2H), 7.81 (dd, phen, 2H), 7.40 (br s, o-
BPh4, 8H), 6.87 (t, 3JHH = 7.0 Hz, m-BPh4, 8H), 6.72 (t, 3JHH = 7.0 Hz, p-
BPh4, 4H), 1.63 (s, C5Me5, 30H). 13C NMR (THF-d8, 5 ꢀC): δ 165.4
(BPh4), 150.2 (phen), 143.2 (phen), 142.8 (phen), 137.4 (BPh4), 131.7
(phen), 129.5 (phen), 126.4 (phen), 126.1 (BPh4), 122.3 (BPh4), 120.3
(C5Me5), 11.0 (C5Me5). 11B NMR (THF-d8, ꢀ70 ꢀC): δ ꢀ5.96 (BPh4).
IR: 3056m, 3035m, 2907m, 2860m, 2730w, 1944w, 1881w, 1819w, 1764w,
1625m, 1580m, 1523s, 1479s, 1425s, 1380 m, 1340w, 1301w, 1266m,
1221w, 1184w, 1146m, 1105m, 1065w, 1032 m, 912w, 849s, 803w, 777w,
731s, 705s, 682s, 644 m, 613s, 509w cmꢀ1. Anal. Calcd for C56H58BN2Y:
C, 78.32; H, 6.81; N, 3.26. Found: C, 78.60; H, 6.89; N, 2.99.
[(C5Me5)2Y(OCPh2)2][BPh4], 10. A solution of 1 (72 mg, 0.11
mmol) in benzene (10 mL) was added to a stirred solution of
benzophenone (34 mg, 0.19 mmol) in benzene (4 mL). The combined
4094
dx.doi.org/10.1021/ic2000409 |Inorg. Chem. 2011, 50, 4092–4106